BOSTON & CAMBRIDGE, England--(BUSINESS WIRE)--Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program (EAP) for ...

CAMBRIDGE, England & LONDON--(BUSINESS WIRE)--Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and ...

Eurostar grant supports application of BioLizard’s AI expertise to Broken String’s INDUCE-seq® platform Resulting technology, called SafeGuide, will enable faster, more cost-effective development of ...

Broken String Biosciences, a gene therapy company based in Cambridge, U.K., has announced a new research collaboration with the Francis Crick Institute in London. The Crick Institute’s researchers ...

Broken String Biosciences launched an early access program (EAP) through which select developers of gene edited therapeutics will be able to use Broken String’s INDUCE-seq ® technology in their own ...

Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that its ...